Study on the molecular regulatory mechanism of microRNA-195 in the invasion and metastasis of colorectal carcinoma

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 3, 2015, Pages 3793-3800

  Yang, Bin ^a   Tan, Zhigang ^b   Song, Yan ^b  

^a Harrison International Peace Hospital   (China)

^b CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Bcl 2; Caco 2; Colorectal cancer; MicroRNA 195; NCM460

Indexed keywords

MICRORNA; MICRORNA 195; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BCL 2 GENE; CANCER INHIBITION; CELL INVASION ASSAY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PROTEIN EXPRESSION; PROTEIN EXPRESSION ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; RNA EXTRACTION; TUMOR INVASION; WESTERN BLOTTING;

EID: 84929379049     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A and Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34: D140-144.
2. Wagner A, Mayr C, Bach D, Illig R, Plaetzer K, Berr F, Pichler M, Neureiter D and Kiesslich T. MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines. Int J Mol Sci 2014; 15: 20134-20157.
3. Liu L, Chen L, Xu Y, Li R and Du X. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun 2010; 400: 236-240.
4. O’Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839-843.
5. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T and Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753-3756.
6. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J and Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010; 251: 499-505.
7. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
9. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH and Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051-4060.
10. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S and Kim VN. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 415-419.
11. Slaby O, Svoboda M, Michalek J and Vyzula R. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009; 8: 102.
12. Wang X, Wang J, Ma H, Zhang J and Zhou X. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med Oncol 2012; 29: 919-927.
13. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP and Zhuang SM. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 2009; 50: 113-121.
14. Zhao XD, He YY, Gao J, Zhao C, Zhang LL, Tian JY and Chen HL. High Expression of Bcl-2 Protein Predicts Favorable Outcome in Non-small Cell Lung Cancer: Evidence from a Systematic Review and Meta-analysis. Asian Pac J Cancer Prev 2014; 15: 8861-8869.
15. Kumar P, Ning Y and Polverini PJ. Endothelial cells expressing Bcl-2 promotes tumor metastasis by enhancing tumor angiogenesis, blood vessel leakiness and tumor invasion. Lab Invest 2008; 88: 740-749.
16. Bruckheimer EM, Brisbay S, Johnson DJ, Gingrich JR, Greenberg N and McDonnell TJ. Bcl-2 accelerates multistep prostate carcinogenesis in vivo. Oncogene 2000; 19: 5251-5258.
17. Choi J, Choi K, Benveniste EN, Rho SB, Hong YS, Lee JH, Kim J and Park K. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res 2005; 65: 5554-5560.
18. Wick W, Wild-Bode C, Frank B and Weller M. BCL-2-induced glioma cell invasiveness depends on furin-like proteases. J Neurochem 2004; 91: 1275-1283.
19. Qu J, Zhao L, Zhang P, Wang J, Xu N, Mi W, Jiang X, Zhang C and Qu J. MicroRNA-195 Chemosensitizes Colon Cancer Cells to the Chemotherapeutic Drug Doxorubicin by Targeting the First Binding Site of BCL2L2 mRNA. J Cell Physiol 2015; 230: 535-545.
20. Yang Y, Li M, Chang S, Wang L, Song T, Gao L, Hu L, Li Z, Liu L, Yao J and Huang C. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells. Mol Med Rep 2014; 10: 2643-2648.
21. Harraz MM, Xu JC, Guiberson N, Dawson TM and Dawson VL. MiR-223 regulates the differentiation of immature neurons. Mol Cell Ther 2014; 2: 18.
22. Wang Y and Lee CG. MicroRNA and cancer--focus on apoptosis. J Cell Mol Med 2009; 13: 12-23.
23. Hummel R, Hussey DJ and Haier J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 2010; 46: 298-311.
24. Zhang B, Pan X, Cobb GP and Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12.
25. Yang G, Wu D, Zhu J, Jiang O, Shi Q, Tian J and Weng Y. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. Oncol Rep 2013; 30: 877-889.